EP0656771A4 - Printed transdermal drug delivery device. - Google Patents

Printed transdermal drug delivery device.

Info

Publication number
EP0656771A4
EP0656771A4 EP93901003A EP93901003A EP0656771A4 EP 0656771 A4 EP0656771 A4 EP 0656771A4 EP 93901003 A EP93901003 A EP 93901003A EP 93901003 A EP93901003 A EP 93901003A EP 0656771 A4 EP0656771 A4 EP 0656771A4
Authority
EP
European Patent Office
Prior art keywords
printed
delivery device
drug delivery
transdermal drug
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93901003A
Other languages
German (de)
French (fr)
Other versions
EP0656771A1 (en
Inventor
Jesus Miranda
Gary W Cleary
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cygnus Inc
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Publication of EP0656771A1 publication Critical patent/EP0656771A1/en
Publication of EP0656771A4 publication Critical patent/EP0656771A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
EP93901003A 1992-08-25 1992-12-10 Printed transdermal drug delivery device. Withdrawn EP0656771A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93504492A 1992-08-25 1992-08-25
US935044 1992-08-25
PCT/US1992/010672 WO1994004109A1 (en) 1992-08-25 1992-12-10 Printed transdermal drug delivery device

Publications (2)

Publication Number Publication Date
EP0656771A1 EP0656771A1 (en) 1995-06-14
EP0656771A4 true EP0656771A4 (en) 1996-07-31

Family

ID=25466511

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93901003A Withdrawn EP0656771A4 (en) 1992-08-25 1992-12-10 Printed transdermal drug delivery device.

Country Status (8)

Country Link
EP (1) EP0656771A4 (en)
JP (1) JPH08502727A (en)
KR (1) KR950702811A (en)
AU (1) AU3247193A (en)
CA (1) CA2142871A1 (en)
FI (1) FI950766A (en)
NO (1) NO950725L (en)
WO (1) WO1994004109A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19649534B4 (en) * 1996-11-29 2004-05-06 Lts Lohmann Therapie-Systeme Ag Packing made of composite packaging for packaging active ingredient-containing patches
DE19814084B4 (en) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation
HU225734B1 (en) * 1999-07-28 2007-07-30 Zoltan Dardai Multilayer plaster for introducing peptidaceous pharmacons in living organisms and process for producing thereof
DE10110391A1 (en) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Highly flexible nicotine transdermal therapeutic system with nicotine as active ingredient
DE10234673B4 (en) 2002-07-30 2007-08-16 Schwarz Pharma Ag Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DE10261696A1 (en) 2002-12-30 2004-07-15 Schwarz Pharma Ag Device for the transdermal administration of rotigotine base
ATE448828T1 (en) 2003-10-27 2009-12-15 Univ Basel TRANSDERMAL DRUG DELIVERY SYSTEM
JP4745747B2 (en) * 2004-08-12 2011-08-10 日東電工株式会社 Fentanyl-containing patch preparation
JP4824963B2 (en) 2004-08-12 2011-11-30 日東電工株式会社 Patch and patch preparation
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
ES2499067T3 (en) 2005-10-13 2014-09-26 Nitto Denko Corporation Transdermal preparation of nicotine and its production method
JP5535497B2 (en) * 2008-03-06 2014-07-02 リンテック株式会社 Transdermal patch
JP5460971B2 (en) * 2008-03-28 2014-04-02 リンテック株式会社 Transdermal patch
HUE027916T2 (en) * 2010-12-14 2016-11-28 Acino Ag Transdermal therapeutic system for application of an agent
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
CA2977814A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007429A1 (en) * 1988-02-12 1989-08-24 Cygnus Research Corporation Printed transdermal drug delivery device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5016652A (en) * 1985-04-25 1991-05-21 The Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4839174A (en) * 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US5064654A (en) * 1989-01-11 1991-11-12 Ciba-Geigy Corporation Mixed solvent mutually enhanced transdermal therapeutic system
IE62662B1 (en) * 1989-01-06 1995-02-22 Elan Corp Plc Use of nicotine in the treatment of conditions susceptible to said treatment
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007429A1 (en) * 1988-02-12 1989-08-24 Cygnus Research Corporation Printed transdermal drug delivery device
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9404109A1 *

Also Published As

Publication number Publication date
NO950725L (en) 1995-04-10
AU3247193A (en) 1994-03-15
CA2142871A1 (en) 1994-03-03
FI950766A0 (en) 1995-02-20
NO950725D0 (en) 1995-02-24
JPH08502727A (en) 1996-03-26
WO1994004109A1 (en) 1994-03-03
KR950702811A (en) 1995-08-23
FI950766A (en) 1995-03-22
EP0656771A1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
EP0656771A4 (en) Printed transdermal drug delivery device.
IL109661A0 (en) Drug delivery device
GB2265088B (en) Electrochemical device for drug delivery
ZA892541B (en) Transdermal drug delivery device
ZA967502B (en) Medicament delivery device.
IL124804A0 (en) Drug delivery device
GR3018890T3 (en) Medicament dispensing device.
GB2319184B (en) Drug delivery device
EP0662851A4 (en) Drug delivery system.
ZA949185B (en) Intradermal drug delivery device
ZA936621B (en) Medicament dispensing device.
EP0581587A3 (en) Base for transdermal administration.
ZA927273B (en) Veterinary transdermal active agent delivery device.
GB9714750D0 (en) Drug delivery device
EP0600754A3 (en) Constant pharmaceutical infuser.
GB9016056D0 (en) Transdermal medicine delivery devices
EP0636363A3 (en) Drug delivery system.
GB2292887B (en) Drug delivery system
ZA922043B (en) Delivery device
ZA931775B (en) Drug delivery devices.
GB9202190D0 (en) Transdermal delivery device
GB9202205D0 (en) Transdermal delivery device
GB9102033D0 (en) Transdermal delivery device
GB9102034D0 (en) Transdermal delivery device
NZ239990A (en) Transdermal delivery device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950222

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: A61K 9/70

A4 Supplementary search report drawn up and despatched

Effective date: 19960617

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CYGNUS, INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CLEARY, GARY W.

Inventor name: MIRANDA, JESUS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CYGNUS, INC.

17Q First examination report despatched

Effective date: 19990819

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000301